TSX:BLCO - Toronto Stock Exchange - CA0717051076 - Common Stock - Currency: CAD
TSX:BLCO (4/22/2025, 7:00:00 PM)
16.66
+0.01 (+0.06%)
The current stock price of BLCO.CA is 16.66 CAD. In the past month the price decreased by -27.41%. In the past year, price decreased by -17.36%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ZEN.CA | ZENTEK LTD | N/A | 167.02M | ||
OTC.CA | OCUMETICS TECHNOLOGY CORP | N/A | 32.94M | ||
COO.CA | OSTROM CLIMATE SOLUTIONS INC | N/A | 2.85M |
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. The company is headquartered in Vaughan, Ontario and currently employs 13,500 full-time employees. The company went IPO on 2022-05-06. The company operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
BAUSCH + LOMB CORP
520 Applewood Crescent
Vaughan ONTARIO CA
Employees: 13300
Company Website: https://ir.bausch.com/
Investor Relations: https://ir.bausch.com/
Phone: 19082552864
The current stock price of BLCO.CA is 16.66 CAD. The price increased by 0.06% in the last trading session.
The exchange symbol of BAUSCH + LOMB CORP is BLCO and it is listed on the Toronto Stock Exchange exchange.
BLCO.CA stock is listed on the Toronto Stock Exchange exchange.
20 analysts have analysed BLCO.CA and the average price target is 27.52 CAD. This implies a price increase of 65.21% is expected in the next year compared to the current price of 16.66. Check the BAUSCH + LOMB CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BAUSCH + LOMB CORP (BLCO.CA) has a market capitalization of 5.89B CAD. This makes BLCO.CA a Mid Cap stock.
BAUSCH + LOMB CORP (BLCO.CA) currently has 13300 employees.
BAUSCH + LOMB CORP (BLCO.CA) has a resistance level at 18.3. Check the full technical report for a detailed analysis of BLCO.CA support and resistance levels.
The Revenue of BAUSCH + LOMB CORP (BLCO.CA) is expected to grow by 4.73% in the next year. Check the estimates tab for more information on the BLCO.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BLCO.CA does not pay a dividend.
BAUSCH + LOMB CORP (BLCO.CA) will report earnings on 2025-04-30, before the market open.
The PE ratio for BAUSCH + LOMB CORP (BLCO.CA) is 19.37. This is based on the reported non-GAAP earnings per share of 0.86 and the current share price of 16.66 CAD. Check the full fundamental report for a full analysis of the valuation metrics for BLCO.CA.
ChartMill assigns a fundamental rating of 4 / 10 to BLCO.CA. While BLCO.CA is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months BLCO.CA reported a non-GAAP Earnings per Share(EPS) of 0.86. The EPS decreased by -16.22% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -2.35% | ||
ROE | -4.9% | ||
Debt/Equity | 0.73 |
ChartMill assigns a Buy % Consensus number of 72% to BLCO.CA. The Buy consensus is the average rating of analysts ratings from 20 analysts.
For the next year, analysts expect an EPS growth of 7.48% and a revenue growth 4.73% for BLCO.CA